New analysis exposes path to affordable lenacapavir for HIV prevention
A new analysis shows that lenacapavir could be produced for as little as $25 per person per year, potentially transforming global efforts to end the HIV epidemic.
Related Articles
Hulk Hogan’s legacy: Wrestling, fame, physical punishment—and a final cardiac blow | MDLinx
Cardiac arrest in wrestling legend Hulk Hogan highlights risks of long-term anabolic steroid use, surgical stress, and musculoskeletal strain on…
Three-Michelin-star Paris restaurant Arpege switches to plant-based dishes
PARIS (Reuters) -French chef Alain Passard, known for his mastery of roasting techniques, has decided to drop almost all animal products from the menu at…
What the world’s healthiest people eat – and how you can do it too
Long before collagen powders and super supplements, people around the world were eating in ways that supported better health, longer lives and happier guts. From…
Efficacy of baricitinib in moderate alopecia areata, severe alopecia areata, alopecia totalis, and alopecia universalis: A real-world comparative study
Alopecia Areata (AA) is an autoimmune condition causing nonscarring hair loss; alopecia totalis (AT) and alopecia universalis (AU) involve extensive scalp loss with poor prognosis.1…
Cholesterol Levels and Cardiovascular Outcomes Following Statin Initiation for Primary Prevention: A Cohort Study
AbstractBackgroundNon-high-density lipoprotein cholesterol (HDL-C) is increasingly incorporated into guidelines along with low-density lipoprotein cholesterol (LDL-C) to guide lipid-lowering therap…
Hematologic Oncology News | Blood Cancers Today
Blood Cancers Today provides hematologists and oncologists with news, education, and information relevant to their patients and practices, featuring exclusive expert interviews.
COVID-19 Vaccination Saved Lives
On December 31, 2019, the World Health Organization (WHO) was informed about a new respiratory illness of unclear etiology in Wuhan, China, and by January…
Anticoagulants for Atrial Fibrillation in Survivors of Intracranial Hemorrhage: A Meta-Analysis of Randomized Trials
View all available purchase options and get full access to this article. Hart R.G., Pearce L.A., Aguilar M.I. Meta -analysis: antithrombotic therapy to prevent stroke…
Isatuximab approved in the EU for the treatment of transplant-eligible MM – SOHO Insider
The European Commission has approved isatuximab in combination with bortezomib, lenalidomide, and dexamethasone (VRd) for the induction treatment of adult patients with newly diagnosed multiple…
Does Lipoprotein(a) Cholesterol Raise the Risk of Stroke?: Joel Kahn, MD: Integrative Cardiologist
Stroke is a feared complication and inheriting the genetic cholesterol Lipoprotein(a) may raise the risk. A new study analyzed a large database for the risk…